Welcome to Dwaey, specifically on Poly (O-2-hydroxyethyl) starch 100gm + Sodium Chlorride page.
This medicine contains important and useful components, as it consists of
Poly (O-2-hydroxyethyl) starch 100gm + Sodium Chlorride is available in the market in concentration.
Poly (O-2-hydroxyethyl) starch 100gm + Sodium Chlorride
Before using Poly (O-2-Hydroxyethyl) Starch 100gm + Sodium Chloride, patients must consult their healthcare provider. This is particularly important for the following groups:
- Kidney Impairment: Caution is required for patients with renal dysfunction or kidney disease. This formulation may exacerbate renal failure or fluid overload, especially with prolonged use.
- Cardiovascular Conditions: In patients with heart failure, hypertension, or those prone to fluid retention, care must be taken as this combination can cause fluid overload and elevate blood pressure. Regular monitoring of heart function and electrolytes is essential.
- Electrolyte Imbalances: The combination contains sodium chloride, which may lead to hypernatremia (high sodium), posing risks to patients, especially those with conditions like renal failure or heart disease. Monitoring sodium levels is critical.
- Coagulation Abnormalities: Patients with bleeding disorders, such as disseminated intravascular coagulation (DIC) or severe thrombocytopenia, should avoid this treatment, as hydroxyethyl starch may interfere with clotting and increase bleeding risk.
- Allergic Reactions: Individuals with a known hypersensitivity to hydroxyethyl starch or sodium chloride should avoid using this product due to the risk of an allergic response, which could include symptoms such as rash, swelling, or difficulty breathing.
Poly (O-2-Hydroxyethyl) Starch 100gm + Sodium Chloride is primarily used for the following indications:
- Plasma Volume Expansion: This combination serves as a volume expander to treat conditions of hypovolemia (low blood volume) caused by blood loss, trauma, surgery, or burns. It helps restore circulating volume and improve blood pressure.
- Shock Management: Used in the management of hypovolemic shock, particularly where volume replacement is critical for maintaining vital organ perfusion and restoring hemodynamic stability.
- Severe Dehydration: When used to treat severe dehydration, the combination of hydroxyethyl starch and sodium chloride helps to improve fluid and electrolyte balance, which is essential for restoring normal physiological function.
- Post-Surgical Recovery: It aids in volume replacement after extensive surgeries, particularly in cases with significant blood loss, ensuring that circulation and electrolyte levels are adequately restored.
This combination should not be used in the following situations:
- Acute Renal Failure: The product is contraindicated in patients with acute kidney injury or severe chronic renal disease, as hydroxyethyl starch may worsen kidney function and increase the risk of fluid retention.
- Severe Bleeding Disorders: It should not be administered to individuals with conditions like disseminated intravascular coagulation (DIC) or severe thrombocytopenia. Hydroxyethyl starch may alter clotting mechanisms and increase bleeding risk.
- Hypernatremia: Contraindicated in patients with elevated sodium levels (hypernatremia), as the sodium chloride component can exacerbate this condition and cause serious complications.
- Allergic Reactions: Known hypersensitivity to hydroxyethyl starch or sodium chloride constitutes a contraindication due to the potential for severe allergic reactions, including anaphylaxis.
- Fluid Overload Conditions: It should be avoided in patients with heart failure or pulmonary edema, as the sodium content and volume expansion could exacerbate these conditions.
Common Side Effects include:
- Headache
- Nausea or vomiting
- Mild rash or itching
- Elevated blood pressure due to fluid retention
- Swelling or edema, especially in the legs or face
Severe Side Effects:
- Anaphylaxis: A severe allergic reaction that may cause difficulty breathing, swelling of the throat, and severe hypotension. Immediate medical intervention is required.
- Acute Renal Failure: Hydroxyethyl starch can exacerbate kidney damage, leading to acute kidney injury. Renal function should be closely monitored.
- Electrolyte Imbalances: Prolonged use may lead to hypernatremia (high sodium levels), causing symptoms such as confusion, seizures, and high blood pressure.
- Coagulation Abnormalities: In some cases, there may be a risk of bleeding or clotting problems due to the effects on platelet function, especially in patients with pre-existing bleeding disorders.
3
Poly (O-2-Hydroxyethyl) Starch 100gm + Sodium Chloride works as a plasma volume expander:
- Hydroxyethyl starch acts by increasing oncotic pressure, which draws fluid from the interstitial space (between cells) into the bloodstream, thereby expanding the plasma volume and improving circulation.
- The sodium chloride component helps restore electrolyte balance, particularly sodium levels, to ensure the proper function of body systems during periods of fluid loss or imbalances. The product helps to increase blood pressure and improve oxygen and nutrient delivery to tissues during states of shock or volume depletion.
Patients taking Poly (O-2-Hydroxyethyl) Starch 100gm + Sodium Chloride should be aware of the following drug interactions:
- Anticoagulants: Use with anticoagulants (e.g., warfarin, heparin) may increase the risk of bleeding. Monitoring coagulation parameters is advised.
- Diuretics: When combined with diuretics (such as furosemide), there may be an increased risk of electrolyte imbalances (e.g., low potassium or sodium), and fluid shifts may occur. Close monitoring is necessary.
- Corticosteroids: Corticosteroids (such as prednisone) may increase fluid retention, and combining them with this formulation could result in excessive fluid accumulation and edema.
- ACE Inhibitors/Angiotensin Receptor Blockers (ARBs): Patients on ACE inhibitors or ARBs may be at higher risk of hyperkalemia (high potassium) and renal impairment when combined with this fluid-expanding product.
The typical adult dose of Poly (O-2-Hydroxyethyl) Starch 100gm + Sodium Chloride depends on the clinical condition:
- For Plasma Volume Expansion: The usual starting dose is 500 to 1,000 mL administered intravenously. The dose may be repeated depending on the patient’s clinical response (such as improvement in blood pressure or urine output).
- For Hypovolemic Shock: An initial dose of 500 to 1,000 mL intravenously is recommended, and further doses can be administered based on the patient’s response and monitoring of vital signs.
- For Surgical Use: Doses may vary depending on the amount of blood lost during surgery. Typically, 500 mL to 1,000 mL may be administered as a bolus, followed by additional doses as required.
The use of Poly (O-2-Hydroxyethyl) Starch 100gm + Sodium Chloride is generally not recommended in pediatric patients due to limited safety data. If its use is necessary, it should be administered in a clinical setting under the supervision of a healthcare professional. Pediatric doses must be adjusted based on the child's weight, clinical condition, and careful monitoring of fluid and electrolyte status.
---
Important Note:
As always, it is essential for patients to consult with a healthcare provider before using Poly (O-2-Hydroxyethyl) Starch 100gm + Sodium Chloride, especially in cases of kidney disease, heart failure, fluid overload, or electrolyte imbalances. Close monitoring of fluid balance, renal function, and electrolytes is critical to prevent adverse reactions.
In patients with renal impairment, the dose of Poly (O-2-Hydroxyethyl) Starch 100gm + Sodium Chloride should be reduced, and renal function should be closely monitored:
- For patients with mild to moderate renal impairment, careful monitoring is required, and adjustments to the dose may be necessary to avoid fluid overload and further kidney damage.
- Severe renal failure is a contraindication for use, as the product may worsen kidney function and lead to complications such as acute kidney injury.
Not available in a medicine form yet